Health Care · Sharpsburg, PANew
Myris Therapeutics, Inc.
Myris Therapeutics, Inc. is a biotechnology company based in Sharpsburg, Pennsylvania. In a Form D filed with the SEC on October 14, 2026, it reported raising $500,000 from 4 investors as part of an offering of up to $4,500,000. The first sale in the offering took place on September 1, 2026.
- 2nd Form D since 2022. Earlier new notices: Apr 29, 2022. All filings on EDGAR
- Still raising. $4M of the $4.5M offering was still unsold at filing.
$2M raised since 2020
2 Form D offerings, as reported to the SEC, the first in Apr 29, 2022. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 14, 2026 | $500K | $4.5M | 4 |
| Apr 29, 2022 | $1.5M | $2M | 8 |
Filing details
- Amount raised
- $500,000
- Offering size
- $4,500,000
- Investors so far
- 4
- First sale
- September 1, 2026
- Securities offered
- Other
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Sharpsburg, Pennsylvania
- Incorporated
- Delaware, 2022
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $500,000 | $4,500,000 | 4 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Similar raises
Lungpacer Medical, Inc.
Exton, PA · filed Oct 147th Form D since 2017Still raising
Plowshare Holdings LLC
Lititz, PA · filed Oct 142nd Form D since 2026Still raising
EpiVario Inc.
Philadelphia, PA · filed Oct 135th Form D since 2018Still raising
Peca Labs, Inc.
Pittsburgh, PA · filed Oct 910th Form D since 2015Still raising